Control Bionics Ltd. (AU:CBL) has released an update. Control Bionics Ltd is set to showcase its innovative medical devices at the Coffee Microcaps Morning Meeting with CEO Jeremy Steele leading the ...

Control Bionics Ltd. (AU:CBL) has released an update. Control Bionics Ltd. has presented its next-generation assistive technology and data measurement solutions, aiming to enhance user experience and ...

MILFORD, Ohio and NEW SOUTH WALES, Australia, April 8, 2021 /PRNewswire/ — Control Bionics, a global assistive technology company specializing in speech generating devices, announced it is partnering ...

Revenue: AU$6.14m (up 15% from FY 2024). Net loss: AU$6.11m (loss widened by 3.3% from FY 2024). AU$0.023 loss per share. We've found 21 US stocks that are forecast to pay a dividend yield of over 6% ...

(from left) Inventor James Schorey and CEO Rob Wong of Control Bionics show off the new wearable device. A Milford company is back with an updated communication tool for ALS and other "locked-in" ...

Commercialisation of its new NeuroStrip wearable tech progressing across sports science, stroke rehab and diagnostics, with trials underway in the US, Japan and Australia. NeuroBounce, its athlete ...

Control Bionics (ASX:CBL) has officially launched its NeuroNode Only sales model in the US following recent issuance of US Medicare reimbursement code E2513 under the Healthcare Common Procedure ...

Control Bionics is on track for record revenue in FY25 driven by strong performance in the US and growth in Australia. Commercialisation of its new NeuroStrip wearable tech progressing across sports ...